SmartMetric (SMME) 10-K11 Oct 132013 FY Annual reportFinancial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
Document And Entity Information (USD $)	Jun. 30, 2013	Sep. 20, 2013	Dec. 31, 2012
Document Information [Line Items]
Entity Registrant Name	SmartMetric, Inc.
Entity Central Index Key	1301991
Current Fiscal Year End Date	-24
Entity Filer Category	Smaller Reporting Company
Trading Symbol	SMME
Entity Common Stock, Shares Outstanding		147,698,950
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	30-Jun-13
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2013
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$23,631,834

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jun. 30, 2013	Jun. 30, 2012
Assets
Cash	$804,257	$889,589
Prepaid expenses and other current assets	799,699	749,162
Total current assets	1,603,956	1,638,751
Other assets:
Patent costs, less accumulated amortization of $13,125 and $11,625, respectively	1,875	3,375
Total assets	1,605,831	1,642,126
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	262,648	132,925
Liability for stock to be issued	216,978	924,392
Deferred Officer salary	61,681	67,026
Shareholder loan	21,572	1,422
Payroll taxes and related fees	0	16,551
Total current liabilities	562,879	1,142,316
Stockholders' equity:
Preferred stock, $.001 par value; 5,000,000 shares authorized, 400,000 and 200,000 shares issued and outstanding, respectively	400	200
Common stock, $.001 par value; 200,000,000 shares authorized, 147,698,950 and 118,974,672 shares issued and outstanding , respectively	147,699	118,975
Additional paid-in capital	16,859,447	11,657,012
Deficit accumulated during the development stage	-15,964,594	-11,276,377
Total Stockholders' equity	1,042,952	499,810
Total liabilities and stockholders' equity	$1,605,831	$1,642,126

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2013	Jun. 30, 2012
Accumulated amortization of patent costs (in dollars)	$13,125	$11,625
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	400,000	200,000
Preferred stock, shares outstanding	400,000	200,000
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	147,698,950	118,974,672
Common stock, shares outstanding	147,698,950	118,974,672

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended		126 Months Ended
Consolidated Statements of Operations (USD $)	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Revenues	$0	$0	$0
Expenses:
Officer's salary	197,500	170,000	1,472,500
Other general and administrative	3,354,798	2,237,532	11,773,361
Research and development	1,135,919	302,381	2,656,907
Total operating expenses	4,688,217	2,709,913	15,902,768
Loss from operations	-4,688,217	-2,709,913	-15,902,768
Interest income	0	0	657
Interest expense	0	0	-62,483
Loss before income taxes	-4,688,217	-2,709,913	-15,964,594
Income taxes	0	0	0
Net loss	($4,688,217)	($2,709,913)	($15,964,594)
Net loss per share, basic and diluted	($0.04)	($0.03)
Weighted average number of common shares outstanding, basic and diluted	130,120,074	106,240,891

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended		126 Months Ended
Consolidated Statements of Cash Flows (USD $)	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	($4,688,217)	($2,709,913)	($15,964,594)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	0	0	15,984
Amortization	1,500	1,500	13,125
Common stock and warrants issued and issuable for services	2,824,387	1,276,246	5,911,986
Interest accrued on convertible notes payable	0	0	2,400
Changes in assets and liabilities
(Increase) decrease in prepaid expenses and other current assets	-50,537	199,588	-799,699
Increase in accounts payable and accrued expenses	129,723	52,043	262,648
(Decrease) increase in liability for stock to be issued	-707,414	-238,271	216,978
(Decrease) increase in deferred officer's salary	-5,345	1,732	61,681
(Decrease) in payroll taxes and related fees	-16,551	-163,413	0
Net cash used in operating activities	-2,512,454	-1,580,488	-10,279,491
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of equipment	0	0	-15,984
Patent costs	0	0	-15,000
Net cash used in investing activities	0	0	-30,984
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable	0	0	60,000
Loans from related parties	20,150	0	94,493
Repayments of loans from related parties	0	-11,000	-72,921
Proceeds from sale of common stock	2,406,972	2,208,478	11,033,160
Net cash provided by financing activities	2,427,122	2,197,478	11,114,732
NET (DECREASE) INCREASE IN CASH	-85,332	616,990	804,257
BEGINNING OF YEAR	889,589	272,599	0
END OF YEAR	804,257	889,589	804,257
CASH PAID DURING THE YEAR FOR:
Income taxes	0	0	0
Interest expense	0	0	62,483
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES
Conversion of notes payable and accrued interest to common stock	0	0	62,400
Issuance of preferred stock and reduction of additional paid in capital for patent	$200	$0	$400

Consolidated_Statement_of_Chan

Consolidated Statement of Changes In Stockholders' Equity (Deficit) (USD $)	Total	Preferred Stock [Member]	Common Stock Class A [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit during Development Stage [Member]
Balance at Dec. 17, 2002	$0	$0	$0	$0	$0	$0
Balance (in shares) at Dec. 17, 2002		0	0	0
Net loss	-60	0	0	0	0	-60
Balance at Jun. 30, 2003	-60	0	0	0	0	-60
Balance, (in shares) at Jun. 30, 2003		0	0	0
Shares issued of common stock and warrants for cash	135,602	0	50,000	8,560	77,042	0
Shares issued of common stock and warrants for cash (in shares)		0	50,000,000	8,560,257
Net loss	-35,978	0	0	0	0	-35,978
Balance at Jun. 30, 2004	99,564	0	50,000	8,560	77,042	-36,038
Balance, (in shares) at Jun. 30, 2004			50,000,000	8,560,257
Costs associated with sale of common stock subject to possible rescission	-95,877	0	0	0	-95,877	0
Net loss	-258,355	0	0	0	0	-258,355
Balance at Jun. 30, 2005	-254,668	0	50,000	8,560	-18,835	-294,393
Balance, (in shares) at Jun. 30, 2005			50,000,000	8,560,257
Shares issued of common stock and warrants for cash	1,198,297	0	0	936	1,197,361	0
Shares issued of common stock and warrants for cash (in shares)		0	0	936,112
Shares issued of common stock for services rendered	20,000	0	0	20	19,980	0
Shares issued of common stock for services rendered (in shares)		0	0	20,000
Conversion of loan payable and accrued interest to common shares	62,400	0	0	40	62,360	0
Conversion of loan payable and accrued interest to common shares (in shares)		0	0	40,000
Conversion of Class A common shares to common shares	0	0	-50,000	50,000	0	0
Conversion of Class A common shares to common shares (in shares)		0	-50,000,000	50,000,000
Net loss	-1,225,045	0	0	0	0	-1,225,045
Balance at Jun. 30, 2006	-199,016	0	0	59,556	1,260,866	-1,519,438
Balance, (in shares) at Jun. 30, 2006		0	0	59,556,369
Shares issued of common stock and warrants for cash	760,349	0	0	1,209	759,140	0
Shares issued of common stock and warrants for cash (in shares)		0	0	1,208,887
Shares issued of common stock for services rendered	0	0	0	192	-192	0
Shares issued of common stock for services rendered (in shares)		0	0	191,505
Net loss	-1,050,189	0	0	0	0	-1,050,189
Balance at Jun. 30, 2007	-488,856	0	0	60,957	2,019,814	-2,569,627
Balance, (in shares) at Jun. 30, 2007		0	0	60,956,761
Shares issued of common stock and warrants for cash	1,300,224	0	0	6,629	1,293,595	0
Shares issued of common stock and warrants for cash (in shares)		0	0	6,629,634
Shares issued of common stock for services rendered	473,400	0	0	2,327	471,073	0
Shares issued of common stock for services rendered (in shares)		0	0	2,327,000
Net loss	-1,397,056	0	0	0	0	-1,397,056
Balance at Jun. 30, 2008	-112,288	0	0	69,913	3,784,482	-3,966,683
Balance, (in shares) at Jun. 30, 2008		0	0	69,913,395
Shares issued of common stock and warrants for cash	443,344	0	0	4,413	438,931	0
Shares issued of common stock and warrants for cash (in shares)		0	0	4,412,596
Shares issued of common stock for services rendered	105,939	0	0	1,059	104,880	0
Shares issued of common stock for services rendered (in shares)		0	0	1,059,394
Transfer of shares from temporary equity to common stock	241,256	0	0	161	241,095	0
Transfer of shares from temporary equity to common stock (in shares)		0	0	160,837
Net loss	-1,103,089	0	0	0	0	-1,103,089
Balance at Jun. 30, 2009	-424,838	0	0	75,546	4,569,388	-5,069,772
Balance, (in shares) at Jun. 30, 2009		0	0	75,546,222
Shares issued for patent	0	200	0	0	-200	0
Shares issued for patent (in shares)		200,000	0	0
Shares issued of common stock and warrants for cash	440,400	0	0	8,808	431,592
Shares issued of common stock and warrants for cash (in shares)		0	0	8,808,000
Shares issued of common stock for services rendered	400,414	0	0	4,858	395,556	0
Shares issued of common stock for services rendered (in shares)		0	0	4,858,333
Warrants issued for services rendered	337,750				337,750
Net loss	-1,611,652	0	0	0	0	-1,611,652
Balance at Jun. 30, 2010	-857,926	200	0	89,212	5,734,086	-6,681,424
Balance, (in shares) at Jun. 30, 2010		200,000	0	89,212,555
Shares issued of common stock and warrants for cash	1,861,278	0	0	10,264	1,851,014	0
Shares issued of common stock and warrants for cash (in shares)		0	0	10,264,030
Shares issued of common stock for services rendered	606,687	0	0	2,226	604,461	0
Shares issued of common stock for services rendered (in shares)		0	0	2,225,750
Net loss	-1,885,040	0	0	0	0	-1,885,040
Balance at Jun. 30, 2011	-275,001	200	0	101,702	8,189,561	-8,566,464
Balance, (in shares) at Jun. 30, 2011		200,000	0	101,702,335
Shares issued of common stock and warrants for cash	2,253,784	0	0	13,149	2,240,635	0
Shares issued of common stock and warrants for cash (in shares)		0	0	13,149,250
Shares issued of common stock for services rendered	1,230,940	0	0	4,124	1,226,816	0
Shares issued of common stock for services rendered (in shares)		0	0	4,123,087
Net loss	-2,709,913	0	0	0	0	-2,709,913
Balance at Jun. 30, 2012	499,810	200	0	118,975	11,657,012	-11,276,377
Balance, (in shares) at Jun. 30, 2012	118,974,672	200,000	0	118,974,672
Shares issued for patent	0	200	0	0	-200	0
Shares issued for patent (in shares)		200,000	0	0
Shares issued of common stock and warrants for cash	2,438,223	0	0	15,379	2,422,844	0
Shares issued of common stock and warrants for cash (in shares)		0	0	15,379,518
Shares issued of common stock for services rendered	2,793,136	0	0	13,345	2,779,791	0
Shares issued of common stock for services rendered (in shares)		0	0	13,344,760
Net loss	-4,688,217	0	0	0	0	-4,688,217
Balance at Jun. 30, 2013	$1,042,952	$400	$0	$147,699	$16,859,447	($15,964,594)
Balance, (in shares) at Jun. 30, 2013	147,698,950	400,000	0	147,698,950

Consolidated_Statement_of_Chan1

Consolidated Statement of Changes In Stockholders' Equity (Deficit) (Parenthetical) (USD $)	12 Months Ended
	Jun. 30, 2006
Noninterest Expense Offering Cost	$138,509

ORGANIZATION_AND_BASIS_OF_PRES

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
ORGANIZATION AND BASIS OF PRESENTATION	Jun. 30, 2013
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION

	SmartMetric, Inc. (the “Company” or “SmartMetric”) was incorporated in the State of Nevada on December 18, 2002. SmartMetric’s main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric Datacard. SmartMetric has completed development of its card along with pre mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards.

	Going Concern

	As shown in the accompanying consolidated financial statements the Company has incurred recurring losses of $4,688,217 and $2,709,913 for the years ended June 30, 2013 and 2012 respectively, and has incurred a cumulative loss of $15,964,594 since inception (December 18, 2002). The Company is currently in the development stage and has spent a substantial portion of its time in the development of its technology.

	There is no guarantee that the Company will be able to raise enough capital or generate revenues to sustain its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

	Management believes that the Company’s capital requirements will depend on many factors. These factors include the final phase of development and mass production being successful as well as product implementation and distribution.

	The consolidated financial statements do not include any adjustments relating to the carrying amounts of recorded assets or the carrying amounts and classification of recorded liabilities that may be required should the Company be unable to continue as a going concern.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Jun. 30, 2013
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

	Development Stage Company

	The Company is considered to be in the development stage as defined in ASC 915-10, "Accounting and Reporting by Development Stage Enterprises". The Company has devoted substantially all of its efforts to the development of its technology. Additionally, the Company has allocated a substantial portion of its time and investment in bringing its services to the market, and the raising of capital.

	Principles of Consolidation

	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.

	Use of Estimates

	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

	Cash and Cash Equivalents

	The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company has no cash equivalents. At June 30, 2013 and 2012, the Company had cash in excess of FDIC insured limits of $594,358 and $0, respectively.

	Fair Value of Financial Instruments

	The carrying amounts reported in the consolidated balance sheet for cash, accounts payable, and accrued expenses including payroll withholdings, interest and penalties approximate fair value because of the immediate or short-term maturity of these financial instruments.

	ASC 820 defines fair value, provides a consistent framework for measuring fair value under generally accepted accounting principles and expands fair value financial statement disclosure requirements. ASC 820’s valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. ASC 820 classifies these inputs into the following hierarchy:

	Level 1inputs: Quoted prices for identical instruments in active markets.

	Level 2 inputs: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

	Level 3 inputs: Instruments with primarily unobservable value drivers.

	Research and Development

	The Company annually incurs costs on activities that relate to research and development of new technology and products. Research and development costs are expensed as incurred.

	Revenue Recognition

	The Company has not recognized revenues to date. The Company anticipates recognizing revenue in accordance with the contracts it enters into for the sale and distribution of its products.

	Accounts Receivable

	The Company will extend credit based on its evaluation of the customers’ financial condition, generally without requiring collateral. Exposure to losses on receivables is expected to vary by customer due to the financial condition of each customer. The Company will monitor exposure to credit losses and maintains allowances for anticipated losses considered necessary under the circumstances. The Company has not recorded any receivables, and therefore no allowance for doubtful accounts.

	Uncertainty in Income Taxes

	GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2013 no accrual for uncertain income tax positions is necessary.

	Advertising Costs

	The Company will expense the cost associated with advertising as incurred.

	Equipment

	Equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated economic useful lives of the assets ranging from 3 - 5 years.

	Impairment of Long-Lived Assets

	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. The Company does not perform a periodic assessment of assets for impairment in the absence of such information or indicators. Conditions that would necessitate an impairment assessment include a significant decline in the observable market value of an asset, a significant change in the extent or manner in which an asset is used, or a significant adverse change that would indicate that the carrying amount of an asset or group of assets is not recoverable. For long-lived assets to be held and used, the Company recognizes an impairment loss only if its carrying amount is not recoverable through its undiscounted cash flows and measures the impairment loss based on the difference between the carrying amount and estimated fair value.

	Loss Per Share of Common Stock

	Basic net loss per common share is computed using the weighted average number of common shares outstanding. The calculation of diluted earnings per share ("EPS") includes consideration of dilution arising from common stock equivalents, such as stock issuable pursuant to the exercise of stock options and warrants. Common stock equivalents were not included in the computation of diluted earnings per share on the consolidated statement of operations due to the fact that the Company reported a net loss and to do so would be anti-dilutive for the periods presented.

	Stock-Based Compensation

The Company measures expense for issuances of stock-based compensation to employees and others at fair value of the stock and warrants issued, as this is more reliable than the fair value of the services received. The fair value is measured at the value of the Company’s common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance obligation is complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital.

Reclassifications

Certain amounts in the 2012 consolidated financial statements have been reclassified for comparative purposes to conform to the presentation in the current year consolidated financial statements. These reclassifications had no effect on previously reported results.

PREPAID_EXPENSES

PREPAID EXPENSES	12 Months Ended
PREPAID EXPENSES	Jun. 30, 2013
Prepaid Expenses [Abstract]
PREPAID EXPENSES	NOTE 3 - PREPAID EXPENSES

	Prepaid expenses represent the unexpired terms of various consulting agreements and expire through September 2014, as well as advance rental payments. These consulting agreements were entered into for the issuance of common stock and warrants and were valued based on the stock price or computed warrant value at the time of the respective agreement.

PATENT_COSTS

PATENT COSTS	12 Months Ended
PATENT COSTS	Jun. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
PATENT COSTS	NOTE 4 - PATENT COSTS

	Patent costs as of June 30, 2013 and June 30, 2012 are summarized as follows:

		Estimated		June		June 30,
		Useful Lives		30,		2012
		( Years)		2013

	Legal fees paid in connection with patent Applications		10	$	15,000	$	15,000

	Less: accumulated amortization				-13,125		-11,625
	Patent costs, net			$	1,875	$	3,375

	Amortization expense was $1,500 for the years ended June 30, 2013 and 2012, respectively.

COMMITMENTS

COMMITMENTS	12 Months Ended
	Jun. 30, 2013
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 5 - COMMITMENTS

	Patent License Agreement

	Effective August 1, 2004, the Company executed a license agreement with Applied Cryptography, Inc. (“ACI”), a corporation controlled by the Company’s president and the owner of certain technology. Pursuant to the license agreement, the Company has the right to make use of this technology for the purpose of developing software and systems to be used by the Company to provide any or all of the following: 1) secure transactions over the Internet from home and office computers; 2) an automatic method for connecting to remote computers; 3) a method of developing targeted advertising to home and/or office computers; and 4) identity verification and access control as provided for in the patent. Pursuant to this license agreement, ACI is to receive 2% of all revenues generated by the Company on products which utilize this patented technology. The license fee is to be paid within 45 days of the end of each quarter. In the event no revenues are generated through the use of any of the licensed patents during a given quarter, no money shall be owed ACI for such quarter. ACI has the right to rescind the license agreement and reclaim all rights and interest in the patents if certain events, such as the Company’s filing for bankruptcy protection or reorganization, occur. The license agreement remains in effect for the lives of the patents. The Company may utilize the technological applications anywhere in the world without limitation. Upon execution of the Assignment and Assumption Agreement on December 11, 2009 (see Note 6), the Patent License Agreement was terminated.

	During November 2012, the Company acquired license rights to ACI's Medical Keyring Device technology in consideration of the Company's issuance to ACI of 200,000 shares of its Series B Convertible Preferred Stock.

	Lease Agreement

	In February 2012, the company entered into a facilities lease in Buenos Aires, Argentina for its manufacturing activities. The lease term is from March 1, 2012 through January 31, 2015. The Company also utilizes offices in Australia, Israel and Las Vegas, Nevada. The Company’s main office is located in Las Vegas, Nevada. Rent expense under all leases for the years ended June 30, 2013 and 2012 was $103,814 and $46,918 respectively. Total minimum future rental payments under all leases with terms in excess of one year are as follows:

	Year ending June 30,	Amount

	2014	$	80,931
	2015		48,558
	Total	$	129,489

	Related Party Transactions

	The Company’s president has made cash advances to the Company with an aggregate amount due of $21,572 and $1,422 as of June 30, 2013 and June 30, 2012, respectively. These advances bear interest at 5.00% per annum.

	As of June 30, 2013 and June 30, 2012, the Company has accrued the amounts of $61,681 and $67,026, respectively, as deferred Officer’s salary for the difference between the president’s annual salary and the amounts paid.

STOCKHOLDERS_EQUITY_DEFICIT

STOCKHOLDERS' EQUITY (DEFICIT)	12 Months Ended
	Jun. 30, 2013
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 6 - STOCKHOLDERS’ EQUITY (DEFICIT)

	Preferred Stock

	As of June 30, 2013, the Company has 5,000,000 shares of preferred stock, par value $0.001, authorized and 400,000 shares issued and outstanding.

	On December 11, 2009, the Company filed a Certificate of Designation with the State of Nevada, to designate 500,000 shares of the preferred stock to be designated as Series B Convertible Preferred Stock (“Series B Convertible Preferred Stock”).

	Each share of Series B Convertible Preferred Stock has a par value of $0.001, and a stated value equal to $5.00 (“Stated Value”). Holders of the Series B Convertible Preferred Stock are entitled to receive dividends or other distributions with the holders of the common stock of the Company on an as converted basis when, as, and if declared by the directors of the Company. Holders of the Series B Convertible Preferred Stock are entitled to convert all or any one (1) share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock.

	Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (“liquidation”), holders of the Series B Convertible Preferred Stock are entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, pro rata with the holders of the common stock.

	On December 11, 2009, the Company entered into an Assignment and Assumption Agreement with ACI (the “Assignment and Assumption Agreement”). In accordance with the Assignment and Assumption Agreement, ACI conveyed, assigned and transferred to the Company all of ACI’s rights, title and interest in and to the Patent (see Note 5) and delegated to the Company all of its duties and obligations to be performed under the Patent; and the Company hereby accepts the assignment of all of ACI’s rights, title and interest to the Patent and the rights and delegation of duties and obligations and agrees to be bound by and to assume such duties and obligations.

	In consideration for the assignment of the Patent, the Company issued 200,000 shares of Series B Convertible Preferred Stock. ACI may only convert these shares into common shares (in accordance with the conversion terms noted herein) upon delivering to the Company, a third party valuation of the assigned Patent conducted by a nationally qualified accounting firm or IP law firm mutually agreed upon between the Company and ACI, indicating that such Patent is valued at a minimum of $1,000,000.

	In connection with the Assignment and Assumption Agreement, the Company and ACI entered into a 24 month option agreement pursuant to which the Company agreed to grant ACI an option to purchase the Patent from the Company for 100,000 shares of Series B Convertible Preferred Stock, only in the event that the Company fails to generate at least $1,000,000 in gross revenues attributable to the Patent at the conclusion of 24 months from the date of the Assignment and Assumption Agreement, December 11, 2011. As of December 11, 2011, ACI did not exercise its option to purchase back the patent within the 24 month option period, and Smartmetric owns, outright, all rights, title and interest in the patent.

	On November 12, 2012, the Company issued 200,000 shares of its Series B Convertible Preferred Stock to ACI in consideration for ACI’s patent relating to the Medical Keyring Device.

	With its biometric “on/off switch,” both the Medical Keyring and Medical Emergency card can instantly deliver all medical records and imaging (video, stills) to medical care providers (the built-in application is both Windows and Mac compatible). Users can track and update their stored medical information, and provide this vital information in any medical emergency. With its visual display, the Keyring also offers emergency instructions to healthcare providers while its Plug and Play USB connection provides a complete medical history. Used by health insurance companies, the Medical Insurance card can also eliminate insurance fraud by uniquely and securely identifying the valid cardholder.

	In accordance with Staff Accounting Bulletin (“SAB”) topic 5G “Transfers of Non-monetary Assets by Promoters and Shareholders” the Company recorded these transactions at ACI’s carrying basis of the Patents.

	Class A Common Stock

	As of June 30, 2013, the Company has 50,000,000 shares of Class A common stock, par value $0.001, authorized and no shares issued and outstanding. In October 2003, the Company issued 50,000,000 shares of Class A common stock at par value ($50,000). These shares were converted into 50,000,000 shares of common stock in 2006.

	Common Stock

	The Company was incorporated on December 18, 2002, with 45,000,000 shares of Common Stock, par value $0.001. The articles of incorporation were amended in 2006 to increase the number of authorized shares to 100,000,000 shares, and again in 2009 to increase the number of authorized shares to 200,000,000.

	As of June 30, 2013, the Company has 147,698,950 shares of common stock issued and outstanding.

	From October 2003 to June 2004, the Company issued 8,560,257 shares to investors at $0.01 for $85,602.

	From August 2005 to February 2006, the Company sold a total of 743,648 shares of common stock at $1.50 per share in its public offering resulting in gross proceeds of $1,115,472. The net proceeds to the Company after deducting $138,471 in offering costs, was $977,001.

	From May 2006 to June 2006, the Company sold a total of 192,464 units at $1.15 per Unit in private placements resulting in gross proceeds of $221,334 and net proceeds of $221,296. Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.50 per share.

	In July 2006, the Company sold a total of 56,522 units at $1.15 per Unit in private placements resulting in net proceeds of $65,000. In August and September 2006, the Company sold a total of 128,377 units at prices ranging between $0.60 to $0.79 per unit in private placements resulting in net proceeds of $83,558. In the three months ended December 31, 2006, the Company sold a total of 344,115 units at prices ranging from $0.48 to $1.00 per unit in private placements resulting in net proceeds of $229,284. In the six months ended March 31, 2007, the Company sold a total of 297,228 Units at prices ranging from $0.55 to $1.00 per unit in private placements resulting in net proceeds of $200,641. In the three months ended June 30, 2007, the Company sold a total of 382,645 units at prices ranging from $0.36 to $0.56 per unit in private placements resulting in net proceeds of $181,866. Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.50 per share.

	In the year ended June 30, 2007, the Company also authorized the issuance of a total of 82,893 Units to various parties for services rendered relating to the public offering and the private placements and a total of 108,612 shares of common stock to various parties relating to the financings.

	In the three months ended September 30, 2007, the Company sold a total of 903,813 units at prices ranging from $0.30 to $0.34 per unit in private placements resulting in net proceeds of $297,633. In the three months ended December 31, 2007, the Company sold a total of 332,500 units at prices ranging from $0.20 to $0.25 per unit in private placements resulting in net proceeds of $64,284. In the three months ended March 31, 2008, the Company sold a total of 1,042,300 units at a price of $0.20 per unit in private placements resulting in net proceeds of $207,967. In the three months ended June 30, 2008, the Company sold a total of 2,961,203 units at prices ranging from $0.20 to $0.25 per unit in private placements resulting in net proceeds of $597,542. Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.00 per share.

	On March 25, 2008, the Company sold 200,000 shares of its common stock at a price of $0.10 per share resulting in net proceeds of $20,000. In the year ended June 30, 2008, the Company sold 1,189,818 shares of its common stock at prices ranging from $0.07 to $0.13 per share resulting in net proceeds of $112,798.

	In the three months ended September 30, 2007, the Company authorized the issuance of a total of 80,000 shares, valued at $24,000 to non-officer directors of the Company for services rendered.

	On January 14, 2008, the Company issued a total of 2,107,000 shares of its common stock, valued at $421,400 to its attorney and two consultants for services rendered. On February 26, 2008, the Company issued 140,000 shares of common stock, valued at $28,000 to its attorney for services rendered.

	In the year ended June 30, 2009, the Company issued 1,059,394 shares of stock for services rendered valued at $105,939; 662,027 shares of common stock in private placements at prices ranging from $0.08 to $0.10 resulting in net proceeds of $49,587; and 3,750,569 units at a price of $0.10 resulting in net proceeds of $393,757. Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.00 per share.

	In the year ended June 30, 2010, the Company has received $154,004 of stock subscriptions for 1,540,040 shares which has been recorded as a liability for stock to be issued. In addition, the Company issued 3,000,000 shares of common stock for investor relations services on November 9, 2009 at a value of $300,000 ($0.10 per share), and 525,000 shares for consulting services on December 15, 2009 at a value of $34,125 ($0.065 per share). The Company issued 1,333,333 shares of common stock for legal services on April 28, 2010 at a value of $66,289 ($0.05 per share). The related expense is included in other general and administrative expenses in the consolidated statement of operations. The company issued 44,795 units in private placements at a price of $0.05 per share and $10.00 per unit, representing 8,959,000 shares and net proceeds of $446,750.

	In the year ended June 30, 2011, the Company sold 34,030 units (representing 8,216,262 shares of stock and warrants to purchase an additional 2,279,028 shares), for net proceeds of 1,999,200. In addition, the Company issued 2,225,750 shares of common stock for legal and consulting services at a value of $460,029.

	In the three months ended June 30, 2011, the Company issued 1,000,000 shares of common stock for services rendered at a value of $282,730 (0.28273 per share).

	In the three months ended September 30, 2011, the Company issued 2,512,500 shares for legal and consulting services valued at $869,125. These issued shares represent legal services of $27,767 in the current period and satisfaction of the liability to issue 1,000,000 shares with an aggregate value of $841,358.

	During the three months ended September 30, 2011, the Company sold 66.894 units representing 3,344,721 shares and twelve month warrants to purchase an additional 3,344,721 shares at $0.80 per share for net proceeds of $668,113. Each unit was offered at $10,000 and consisted of 50,000 shares and one twelve month warrant to buy an additional 50,000 shares at $0.80 per share.
	During the three months ended December 31, 2011 the Company sold 11.5 units representing 575,000 shares and twelve month warrants to purchase an additional 575,000 shares at $0.80 per share for net proceeds of $114,800. Each unit was offered at $10,000 and consisted of 50,000 shares and one twelve month warrant to buy an additional 50,000 shares at $0.80 per share.

During the three months ended March 31, 2012, the Company issued 765,713 shares for legal and consulting services valued at $102,881.

During the three months ended March 31, 2012, the Company sold 149.96 units representing 7,498,099 shares and twelve month warrants to purchase an additional 7,498,099 shares at $0.80 per share for net proceeds of $999,059. Units were offered at $5,000 and $10,000 and consisted of 50,000 shares and one twelve month warrant to purchase an additional 50,000 shares at $0.80 per share.
During the three months ended June 30, 2012, the Company sold 2,135,000 shares for cash and twelve month warrants to purchase an additional 2,135,000 shares for net proceeds of $426,487. Each share was valued at $0.20.

During the three months ended June 30, 2012, the Company authorized to be issued 3,881,978 shares for services. These shares ranged in value from $0.05 to $0.26.

During the three months ended September 30, 2012, the Company sold 860,000 shares and twelve month warrants to purchase an additional 860,000 shares at $0.80 per share for net proceeds of $171,758.

During the three months ended September 30, 2012, the Company authorized to be issued 4,379,122 shares for legal and consulting services valued at $627,899.

During the three months ended December 31, 2012, the Company sold for cash 200,000 shares and twelve month warrants to purchase an additional 200,000 shares at $0.80 per share. The Company also sold for cash 125,000 shares and twelve month warrants to purchase an additional 125,000 shares at $0.50 per share. Total net proceeds received was $60,041.

During the three months ended December 31, 2012, the Company authorized to be issued 5,575,000 shares for consulting services valued at $1,115,000.

During the three months ended March 31, 2013, the Company sold for cash 4,131,328 shares and twelve month warrants to purchase an additional 4,131,328 shares at $0.50 per share for net proceeds of $672,380.

During the three months ended June 30, 2013, the Company sold for cash 10,097,331 shares and twelve month warrants to purchase an additional 10,097,331 shares at $0.50 per share for net proceeds of $1,499,793.

Warrants

From time to time the Company granted warrants in connection with private placements of securities, as described herein.

In October 2009, the Company executed a warrant agreement with an investor relations company for 5,000,000 warrants to be issued in two tranches. The first tranche of 2,500,000 warrants (the “October warrants”) has been issued in October 2009, and the second tranche of 2,500,000 warrants has been issued on March 31, 2010 (the “March warrants”). The October warrants, which were initially set to expire October 25, 2012 but have been extended by the Company to expire on October 25, 2014, have strike prices as follows: 1,000,000 at $0.10 per share; 1,000,000 at $0.15 per share; and 500,000 at $0.20 per share. The March warrants, which were initially set to expire March 29, 2013 but have been extended by the Company to expire on March 29, 2015, have strike prices as follows: 500,000 at $0.20 per share; 1,000,000 at $0.25 per share; and 1,000,000 at $0.30 per share.

In June 2011, the Company issued warrants to purchase 1,000,000 shares of its common stock at an exercise price of $0.50 per share as partial consideration for a consulting agreement. These warrants were initially set to expire on June 3, 2012 but have been extended by the Company to expire on June 3, 2014.

In connection with the extension of the above referenced warrants, the Company assigned a value of $364,077 using the Black-Scholes option pricing model. The Company recorded the charge to consulting expenses, included as a component of other general and administrative expenses, during the six months ended December 31, 2012.

In May 2012, the Company issued warrants to purchase 250,000 shares of its common stock at an exercise price of $0.50 per share, as partial consideration for a consulting agreement for public relations services. The warrants expire in May 2014.

As of June 30, 2013 and June 30, 2012, the following is a breakdown of the activity:

June 30, 2013:

Outstanding - beginning of year		18,802,820
Issued		16,507,578
Exercised		-
Expired		-13,552,820

Outstanding - end of year		21,757,578

June 30, 2012:

Outstanding - beginning of year		8,279,028
Issued		13,802,820
Exercised		-
Expired		-3,279,028

Outstanding - end of year		18,802,820

At June 30, 2013, all of the 21,757,578 warrants are vested and 15,507,578 warrants expire at various times through June 30, 2014, 250,000 warrants expire on May 8, 2014, 1 million warrants expire on June 20, 2014, 2.5 million warrants expire on October 25, 2014, and 2.5 million warrants expire on March 29, 2015. The Company valued the May 2012 warrants using the Black-Scholes method with the following criteria: stock price of $0.26; strike price of $0.50; volatility 148% and interest rate of 0.27%. The criteria yielded an option value of $0.16 resulting in a value of $39,266 for the 250,000 warrants. The expense has been included in other general and administrative expenses in the consolidated statement of operations.

INCOME_TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Jun. 30, 2013
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 7 - INCOME TAXES

	Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Company’s assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Company’s tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense.

	At June 30, 2013 and 2012, deferred tax assets consist of the following:

		2013			2012
	Net operating loss carryforward	$	4,495,399		$	3,610,256
	Warrant issuances		171,374			171,374
	Other		22,604			23,775
	Valuation allowance		-4,689,377			-3,805,405
		$	-		$	-


	A reconciliation of the activity related to the liability for gross unrecognized tax benefits during fiscal 2013 and 2012 is as follows:

		Year ended June 30,
		2013			2012
	Balance as of beginning of fiscal year	$	164,869		$	114,835
	Increases related to prior year positions		-			50,034
	Balance as of June 30,	$	164,869		$	164,869

	The increase related to prior year positions recorded in 2012 was primarily related to expenses for warrants issued by the Company for services and represents a timing difference only.

	At June 30, 2013, the Company had a net operating loss carryforwards in the amount of $13,221,763 available to offset future taxable income through 2032, which will begin to expire in 2022. The Company established valuation allowances equal to the full amount of the deferred tax assets due to the uncertainty of the utilization of the operating losses in future periods. A reconciliation of the Company’s effective tax rate as a percentage of income before taxes and federal statutory rate for the period ended June 30, 2013 and 2012 is summarized as follows:

		2013			2012
	Tax on income before income tax		34	%		34	%
	Effect of nontemporary differences		-0.66	%		-1.04	%
	Effect of NOL true-up adjustment		-14.48	%		0	%
	Change in valuation allowance		-18.86	%		-32.96	%
			0	%		0	%

	The total amount of unrecognized tax benefits can change due to tax examination activities, lapse of applicable statutes of limitations and the recognition and measurement criteria under the guidance related to accounting for uncertainty in income taxes. The Company does not believe any significant increases or decreases will occur within the next twelve months.

	The Company files income tax returns in the United States ("U.S.") federal jurisdiction. Generally, the Company is no longer subject to U.S. federal examinations by tax authorities for fiscal years prior to 2009. The Company does not file in any other jurisdiction and remains open for audit for all tax years as the statute of limitations does not begin until the returns are filed.

LITIGATION

LITIGATION	12 Months Ended
	Jun. 30, 2013
Litigation [Abstract]
LITIGATION	NOTE 8 - LITIGATION

	On July 27, 2010, the Company filed a second amended complaint (the “Visa and Mastercard Complaint”) in the United States District Court, Central District of California (the “Court”), Case No. 2:10-cv-01864, against MasterCard, Inc. and Visa, Inc. alleging patent infringement on the Company’s patent, U.S. Patent 6,792,464 (the “’464 Patent”) (the “Visa and Mastercard Case”).

	On December 7, 2010, the Company filed a complaint (the “AMEX Complaint”) in the Court, Case No. CV10-9371 JHN (MANx), against American Express Company (“AMEX”) alleging patent infringement on the 464 Patent (the “AMEX Case”).

	On June 30, 2011, the Company filed a Notice of Appeal to the Judgment in the AMEX Case against what the Company believes to be erroneous definition and limitations placed on the 464 patent as a result of wrongful interpretation. On July 1, 2011, the Company filed a Notice of Appeal to the Judgment in the Visa and Mastercard Case against what the Company believes to be erroneous interpretation of definitions and limitations placed on the 464 patent by the Court.

	On August 29, 2011, the Company filed a complaint in the Court, against Master Card, Inc. (“MasterCard”) and Visa, Inc. (“Visa”) alleging patent infringement on the 464 patent. The Company is seeking the following relief from MasterCard and Visa:

	1.	For an order pursuant to 35 U.S.C. section 271 declaring that both MasterCard and Visa have infringed one or more claims of the ‘464 Patent;
	2.	A preliminary and permanent injunction against both MasterCard and Visa prohibiting each of them from further infringement of the ‘464 Patent;
	3.	An award of actual damages the Company has suffered by reason of the infringement charged in the complaint in an amount not less than a reasonable royalty on both MasterCard’s and Visa’s infringement of the ‘464 Patent:
	4.	An award to the Company of its costs; and
	5.	Such other relief as the Court may deem just and proper.

	On April 11, 2012, the United States Court of Appeals for the Federal Circuit (the "Appeals Court") affirmed the Judgment of the Court in the Visa and Mastercard case and the AMEX case. While the Appeals Court affirmed the Judgment, it stated that the Court erroneously limited the definition of network service providers even though its construction of "insertion of said data card into said data card reader" was correct. Moreover, the Court stated that it saw no reason why a data card that communicates with a card reader using an embedded antenna cannot also be inserted into a data card reader to immediately trigger an application program.

	The Company has served a claim for damages and paid up royalty for an aggregate amount of $13.4 billion in connection with its patent infringement litigation against Mastercard and Visa, Inc. In October 2013, the Court held that the Defendants did not infringe on the ‘464 Patent. The Company believes this holding is in error and plans to appeal the ruling.

	The Company intends to continue to vigorously pursue its infringement claim in the Visa and MasterCard case.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Jun. 30, 2013
Development Stage Company	Development Stage Company

	The Company is considered to be in the development stage as defined in ASC 915-10, "Accounting and Reporting by Development Stage Enterprises". The Company has devoted substantially all of its efforts to the development of its technology. Additionally, the Company has allocated a substantial portion of its time and investment in bringing its services to the market, and the raising of capital.

Principles of Consolidation	Principles of Consolidation

	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, SmartMetric Australia Pty. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates	Use of Estimates

	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to income taxes and contingencies. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

Cash and Cash Equivalents	Cash and Cash Equivalents

	The Company considers all highly liquid debt instruments and other short-term investments with an initial maturity of three months or less to be cash equivalents. Any amounts of cash in financial institutions which exceed FDIC insured limits exposes the Company to cash concentration risk. The Company has no cash equivalents. At June 30, 2013 and 2012, the Company had cash in excess of FDIC insured limits of $594,358 and $0, respectively.

Fair Value of Financial Instruments	Fair Value of Financial Instruments

	The carrying amounts reported in the consolidated balance sheet for cash, accounts payable, and accrued expenses including payroll withholdings, interest and penalties approximate fair value because of the immediate or short-term maturity of these financial instruments.

	ASC 820 defines fair value, provides a consistent framework for measuring fair value under generally accepted accounting principles and expands fair value financial statement disclosure requirements. ASC 820’s valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. ASC 820 classifies these inputs into the following hierarchy:

	Level 1inputs: Quoted prices for identical instruments in active markets.

	Level 2 inputs: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

	Level 3 inputs: Instruments with primarily unobservable value drivers.

Research and Development	Research and Development

	The Company annually incurs costs on activities that relate to research and development of new technology and products. Research and development costs are expensed as incurred.

Revenue Recognition	Revenue Recognition

	The Company has not recognized revenues to date. The Company anticipates recognizing revenue in accordance with the contracts it enters into for the sale and distribution of its products.

Accounts Receivable	Accounts Receivable

	The Company will extend credit based on its evaluation of the customers’ financial condition, generally without requiring collateral. Exposure to losses on receivables is expected to vary by customer due to the financial condition of each customer. The Company will monitor exposure to credit losses and maintains allowances for anticipated losses considered necessary under the circumstances. The Company has not recorded any receivables, and therefore no allowance for doubtful accounts.

Uncertainty in Income Taxes	Uncertainty in Income Taxes

	GAAP requires the recognition and measurement of uncertain income tax positions using a “more-likely-than-not” approach. Management evaluates Company tax positions on an annual basis and has determined that as of June 30, 2013 no accrual for uncertain income tax positions is necessary.

Advertising Costs	Advertising Costs

	The Company will expense the cost associated with advertising as incurred.

Equipment	Equipment

	Equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated economic useful lives of the assets ranging from 3 - 5 years.

Impairment of Long-Lived Assets	Impairment of Long-Lived Assets

	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. The Company does not perform a periodic assessment of assets for impairment in the absence of such information or indicators. Conditions that would necessitate an impairment assessment include a significant decline in the observable market value of an asset, a significant change in the extent or manner in which an asset is used, or a significant adverse change that would indicate that the carrying amount of an asset or group of assets is not recoverable. For long-lived assets to be held and used, the Company recognizes an impairment loss only if its carrying amount is not recoverable through its undiscounted cash flows and measures the impairment loss based on the difference between the carrying amount and estimated fair value.

Loss Per Share of Common Stock	Loss Per Share of Common Stock

	Basic net loss per common share is computed using the weighted average number of common shares outstanding. The calculation of diluted earnings per share ("EPS") includes consideration of dilution arising from common stock equivalents, such as stock issuable pursuant to the exercise of stock options and warrants. Common stock equivalents were not included in the computation of diluted earnings per share on the consolidated statement of operations due to the fact that the Company reported a net loss and to do so would be anti-dilutive for the periods presented.

Stock-Based Compensation	Stock-Based Compensation

	The Company measures expense for issuances of stock-based compensation to employees and others at fair value of the stock and warrants issued, as this is more reliable than the fair value of the services received. The fair value is measured at the value of the Company’s common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance obligation is complete. The fair value of the equity instrument is charged directly to compensation expense and additional paid-in capital.

Reclassifications	Reclassifications

	Certain amounts in the 2012 consolidated financial statements have been reclassified for comparative purposes to conform to the presentation in the current year consolidated financial statements. These reclassifications had no effect on previously reported results.

PATENT_COSTS_Tables

PATENT COSTS (Tables)	12 Months Ended
PATENT COSTS (Tables)	Jun. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Patent costs as of June 30, 2013 and June 30, 2012 are summarized as follows:

		Estimated		June		June 30,
		Useful Lives		30,		2012
		( Years)		2013

	Legal fees paid in connection with patent Applications		10	$	15,000	$	15,000

	Less: accumulated amortization				-13,125		-11,625
	Patent costs, net			$	1,875	$	3,375

COMMITMENTS_Tables

COMMITMENTS (Tables)	12 Months Ended
COMMITMENTS (Tables)	Jun. 30, 2013
Commitments and Contingencies Disclosure [Abstract]
Contractual Obligation, Fiscal Year Maturity Schedule	Total minimum future rental payments under all leases with terms in excess of one year are as follows:

	Year ending June 30,	Amount

	2014	$	80,931
	2015		48,558
	Total	$	129,489

STOCKHOLDERS_EQUITY_DEFICIT_Ta

STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	12 Months Ended
STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	Jun. 30, 2013
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	June 30, 2013:

	Outstanding - beginning of year	18,802,820
	Issued	16,507,578
	Exercised	-
	Expired	-13,552,820

	Outstanding - end of year	21,757,578

	June 30, 2012:

	Outstanding - beginning of year	8,279,028
	Issued	13,802,820
	Exercised	-
	Expired	-3,279,028

	Outstanding - end of year	18,802,820

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Jun. 30, 2013
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities	At June 30, 2013 and 2012, deferred tax assets consist of the following:

		2013			2012
	Net operating loss carryforward	$	4,495,399		$	3,610,256
	Warrant issuances		171,374			171,374
	Other		22,604			23,775
	Valuation allowance		-4,689,377			-3,805,405
		$	-		$	-

Schedule of Unrecognized Tax Benefits	A reconciliation of the activity related to the liability for gross unrecognized tax benefits during fiscal 2013 and 2012 is as follows:

		Year ended June 30,
		2013			2012
	Balance as of beginning of fiscal year	$	164,869		$	114,835
	Increases related to prior year positions		-			50,034
	Balance as of June 30,	$	164,869		$	164,869

Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the Company’s effective tax rate as a percentage of income before taxes and federal statutory rate for the period ended June 30, 2013 and 2012 is summarized as follows:

		2013			2012
	Tax on income before income tax		34	%		34	%
	Effect of nontemporary differences		-0.66	%		-1.04	%
	Effect of NOL true-up adjustment		-14.48	%		0	%
	Change in valuation allowance		-18.86	%		-32.96	%
			0	%		0	%

ORGANIZATION_AND_BASIS_OF_PRES1

ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) (USD $)

6 Months Ended

12 Months Ended

126 Months Ended

Jun. 30, 2003

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2011

Jun. 30, 2010

Jun. 30, 2009

Jun. 30, 2008

Jun. 30, 2007

Jun. 30, 2006

Jun. 30, 2005

Jun. 30, 2004

Jun. 30, 2013

Entity Incorporation, Date Of Incorporation

18-Dec-02

Entity Incorporation, State Country Name

State of Nevada

Description of Activities of Parent Company

SmartMetrics main product is a fingerprint sensor-activated card with a finger sensor onboard the card and a built-in rechargeable battery for portable biometric identification. This card may be referred to as a biometric card or the SmartMetric Biometric Datacard. SmartMetric has completed development of its card along with pre mass manufacturing cards but has not yet begun to mass manufacture the biometric fingerprint activated cards.

Net Income (Loss) Attributable To Parent

($60)

($4,688,217)

($2,709,913)

($1,885,040)

($1,611,652)

($1,103,089)

($1,397,056)

($1,050,189)

($1,225,045)

($258,355)

($35,978)

($15,964,594)

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Property, Plant and Equipment, Depreciation Methods	straight line basis
Cash, FDIC Insured Amount	$594,358	$0
Minimum [Member]
Property, Plant and Equipment, Estimated Useful Lives	3
Maximum [Member]
Property, Plant and Equipment, Estimated Useful Lives	5

PATENT_COSTS_Details

PATENT COSTS (Details) (USD $)	12 Months Ended
PATENT COSTS (Details) (USD $)	Jun. 30, 2013	Jun. 30, 2012
Less: accumulated amortization	($13,125)	($11,625)
Patent costs, net	1,875	3,375
Patents [Member]
Legal fees paid in connection with patent Applications	15,000	15,000
Less: accumulated amortization	-13,125	-11,625
Patent costs, net	$1,875	$3,375
Legal fees paid in connection with patent Applications, Estimated Useful Lives (Years)	10 years

PATENT_COSTS_Details_Textual

PATENT COSTS (Details Textual) (USD $)	12 Months Ended		126 Months Ended
PATENT COSTS (Details Textual) (USD $)	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Amortization	$1,500	$1,500	$13,125
Patents [Member]
Amortization	$1,500	$1,500

COMMITMENTS_Details

COMMITMENTS (Details) (USD $)	Jun. 30, 2013
Year ending June 30,
2014	$80,931
2015	48,558
Total	$129,489

COMMITMENTS_Details_Textual

COMMITMENTS (Details Textual) (USD $)	12 Months Ended		0 Months Ended		1 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Nov. 12, 2012	Nov. 12, 2012	Dec. 31, 2009
			Series B Convertible Preferred Stock [Member]	Applied Cryptography, Inc [Member]	Applied Cryptography, Inc [Member]
				Series B Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]
License Agreement Initiation Date	1-Aug-04
Percentage Of Revenue To Be Paid As License Fee	2.00%
License Fee Periodic Payment Description	The license fee is to be paid within 45 days of the end of each quarter.
Lease Agreement Initiation Date	Feb-12
Lease Initiation Date	1-Mar-12
Lease Expiration Date	31-Jan-15
Operating Leases, Rent Expense	$103,814	$46,918
Due to Related Parties	21,572	1,422
Related Party Transaction, Rate	5.00%	5.00%
Deferred Compensation Liability, Current	$61,681	$67,026
Stock Issued During Period, Shares, New Issues			200,000	200,000	200,000

STOCKHOLDERS_EQUITY_DEFICIT_De

STOCKHOLDERS' EQUITY (DEFICIT) (Details)	12 Months Ended
STOCKHOLDERS' EQUITY (DEFICIT) (Details)	Jun. 30, 2013	Jun. 30, 2012	Oct. 31, 2009
Outstanding - end of year	21,757,578
Warrant [Member]
Outstanding - beginning of year	18,802,820	8,279,028	5,000,000
Issued	16,507,578	13,802,820
Exercised	0	0
Expired	-13,552,820	-3,279,028
Outstanding - end of year	21,757,578	18,802,820	5,000,000

STOCKHOLDERS_EQUITY_DEFICIT_De1

STOCKHOLDERS' EQUITY (DEFICIT) (Details Textual) (USD $)	3 Months Ended							12 Months Ended									126 Months Ended		3 Months Ended					3 Months Ended		1 Months Ended	2 Months Ended		3 Months Ended						6 Months Ended	10 Months Ended	12 Months Ended			2 Months Ended	3 Months Ended					6 Months Ended	2 Months Ended	3 Months Ended					6 Months Ended	1 Months Ended		3 Months Ended	12 Months Ended			1 Months Ended					1 Months Ended				12 Months Ended					3 Months Ended														0 Months Ended			1 Months Ended		3 Months Ended	12 Months Ended	1 Months Ended	0 Months Ended			1 Months Ended		3 Months Ended									9 Months Ended	12 Months Ended						3 Months Ended				12 Months Ended	3 Months Ended	12 Months Ended	7 Months Ended	12 Months Ended					3 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2009	Jun. 30, 2008	Jun. 30, 2007	Jun. 30, 2006	Jun. 30, 2004	Jun. 30, 2013	Dec. 11, 2009	Sep. 30, 2011	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Dec. 31, 2012	Mar. 31, 2012	Dec. 31, 2012	Jul. 31, 2006	Sep. 30, 2006	Jun. 30, 2006	Jun. 30, 2008	Mar. 31, 2008	Dec. 31, 2007	Sep. 30, 2007	Jun. 30, 2007	Dec. 31, 2006	Mar. 31, 2007	Jun. 30, 2008	Jun. 30, 2010	Jun. 30, 2009	Jun. 30, 2007	Sep. 30, 2006	Jun. 30, 2008	Dec. 31, 2007	Sep. 30, 2007	Jun. 30, 2007	Dec. 31, 2006	Mar. 31, 2007	Sep. 30, 2006	Jun. 30, 2008	Dec. 31, 2007	Sep. 30, 2007	Jun. 30, 2007	Dec. 31, 2006	Mar. 31, 2007	31-May-12	Jun. 30, 2011	Sep. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Oct. 31, 2009	Oct. 31, 2009	Mar. 31, 2010	Oct. 31, 2009	Oct. 31, 2009	Oct. 31, 2009	Mar. 31, 2010	Mar. 31, 2010	Mar. 31, 2010	Mar. 31, 2010	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Dec. 31, 2012	Dec. 31, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2011	Dec. 11, 2009	Nov. 12, 2012	Dec. 11, 2009	Nov. 12, 2012	Dec. 31, 2009	Oct. 31, 2003	Jun. 30, 2013	Jun. 30, 2006	Apr. 28, 2010	Dec. 15, 2009	Nov. 09, 2009	Jan. 14, 2008	Mar. 25, 2008	Feb. 26, 2008	Jun. 30, 2013	Mar. 31, 2013	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Sep. 30, 2007	Jun. 30, 2004	Jun. 30, 2011	Jun. 30, 2009	Jun. 30, 2008	Jun. 30, 2007	Dec. 18, 2012	Jun. 30, 2006	Sep. 30, 2012	Mar. 31, 2012	Mar. 31, 2012	Jun. 30, 2012	Jun. 30, 2008	Jun. 30, 2012	Jun. 30, 2008	Feb. 28, 2006	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2009	Jun. 30, 2009	Jun. 30, 2009	Mar. 31, 2013
																			Legal and Consultancy Services [Member]	Each Unit Offering [Member]	Each Unit Offering [Member]	Each Unit Offering [Member]	Issue One [Member]	Issue One [Member]	Issue Two [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Warrant [Member]	Warrant [Member]	Warrant [Member]	Warrant [Member]	Warrant [Member]	Warrant [Member]	October Warrant 2009 [Member]	March Warrant [Member]	October Warrant One 2009 [Member]	October Warrant Two 2009 [Member]	October Warrant Three 2009 [Member]	March Warrant 2010 [Member]	March Warrant One 2010 [Member]	March Warrant Two 2010 [Member]	March Warrant Three 2010 [Member]	May Warrant 2012 [Member]	May 8, 2014 Warrant [Member]	June 20, 2014 Warrant [Member]	October 25, 2014 Warrant [Member]	March 29, 2015 Warrrant [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Twelve Month Warrants [Member]	Patents [Member]	Patents [Member]	Applied Cryptography, Inc [Member]	Applied Cryptography, Inc [Member]	Series B Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Common Class [Member]	Common Class [Member]	Common Class [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]	Common Stock [Member]
																								Legal and Consultancy Services [Member]																Minimum [Member]	Minimum [Member]	Minimum [Member]	Minimum [Member]	Minimum [Member]	Minimum [Member]	Minimum [Member]	Maximum [Member]	Maximum [Member]	Maximum [Member]	Maximum [Member]	Maximum [Member]	Maximum [Member]	Maximum [Member]																										Each Unit Offering [Member]	Each Unit Offering [Member]	Each Unit Offering [Member]	Issue One [Member]	Issue Two [Member]			Patents [Member]	Patents [Member]			Applied Cryptography, Inc [Member]	Applied Cryptography, Inc [Member]																										Legal and Consultancy Services [Member]	Legal and Consultancy Services [Member]	Each Unit Offering [Member]	Minimum [Member]	Minimum [Member]	Maximum [Member]	Maximum [Member]	Ipo [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Private Placement [Member]	Twelve Month Warrants [Member]
																																																																																																																																Minimum [Member]	Maximum [Member]
Preferred stock, shares authorized	5,000,000		5,000,000					5,000,000	5,000,000								5,000,000																																																																								500,000
Preferred Stock, Par Value Per Share	$0.00							$0.00									$0.00																																																																								$0.00
Preferred Stock, Stated Value Per Share																																																																																									$5
Preferred stock, shares issued	400,000		200,000					400,000	200,000								400,000
Preferred stock, shares outstanding	400,000		200,000					400,000	200,000								400,000	500,000
Conversion of Stock, Description																																																																																									Holders of the Series B Convertible Preferred Stock are entitled to convert all or any one (1) share of the Series B Convertible Preferred Stock into fifty (50) shares of common stock.
Stock Issued During Period, Shares, Issued for Cash																																																																																																					10,097,331			2,135,000									1,189,818
Stock Issued During Period, Shares, New Issues																																					8,959,000																	250,000	1,000,000	860,000																							50,000	50,000	50,000							200,000		200,000	200,000	50,000,000							200,000			4,131,328			7,498,099	575,000	3,344,721			8,560,257	8,216,262													743,648
Stock Issued During Period, Value, New Issues								$2,438,223	$2,253,784	$1,861,278	$440,400	$443,344	$1,300,224	$760,349	$1,198,297	$135,602																																							$364,077																																																							$85,602
Finite-Lived Intangible Assets, Gross																																																																																				15,000	15,000	1,000,000
Stock Repurchase Program, Number of Shares Authorized to be Repurchased																																																																																							100,000
Revenue To Be Generated To Retain Patent																																																																																							1,000,000
Common stock, shares authorized	200,000,000		200,000,000					200,000,000	200,000,000								200,000,000																																																																												50,000,000																			200,000,000			45,000,000	100,000,000
Common Stock, Par Or Stated Value Per Share	$0.00		$0.00					$0.00	$0.00								$0.00																																																																											$50,000	$0.00																						$0.00
Common stock, shares issued	147,698,950		118,974,672					147,698,950	118,974,672								147,698,950						200,000		125,000																																																																				0
Common stock, shares outstanding	147,698,950		118,974,672					147,698,950	118,974,672								147,698,950																																																																												0
Conversion of Stock, Shares Converted																																																																																														50,000,000
Equity Issuance, Per Share Amount							$0.28																																																																																								$0.05	$0.07	$0.10		$0.10											$0.01										$0.05	$0.07	$0.26	$0.13	$1.50		$0.05		$0.08	$0.10
Proceeds From Issuance Of Common Stock Gross		60,041																										221,334																																																																																																1,115,472
Noninterest Expense Offering Cost															138,509																																																																																																													138,471
Proceeds from sale of common stock								2,406,972	2,208,478								11,033,160																																																																																		20,000												1,999,200		112,798											977,001			49,587
Number Of Stock Units Sold During Period				149.96	11.5	66.894				34,030																56,522	128,377	192,464	2,961,203	1,042,300	332,500	903,813	382,645	344,115	297,228		44,795	3,750,569
Each unit offering value																					10,000	10,000																																																									10,000																																								5,000
Stock Units Sold Per Unit Amount	$0.50			$0.80	$0.80	$0.80						$0.10								$0.80	$0.80	$0.80				$1.15		$1.15		$0.20							$10	$0.10		$0.60	$0.20	$0.20	$0.30	$0.36	$0.48	$0.55	$0.79	$0.25	$0.25	$0.34	$0.56	$1	$1			$0.80																																														$0.50
Proceeds From Issuance Of Stock Units Net			426,487	999,059	114,800	668,113																				65,000	83,558	221,296	597,542	207,967	64,284	297,633	181,866	229,284	200,641		446,750	393,757																		171,758																																					1,499,793									672,380
Description Of Stock Units Sold				Units were offered at $5,000 and $10,000 and consisted of 50,000 shares and one twelve month warrant to purchase an additional 50,000 shares at $0.80 per share.	Each unit was offered at $10,000 and consisted of 50,000 shares and one twelve month warrant to buy an additional 50,000 shares at $0.80 per share.	Each unit was offered at $10,000 and consisted of 50,000 shares and one twelve month warrant to buy an additional 50,000 shares at $0.80 per share.																						Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.50 per share.								Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.00 per share.		Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.00 per share.	Each unit consisted of one share of common stock and one warrant exercisable for 12 months from the date of issue into one share of common stock at $1.50 per share.
Number Of Stock Units, Authorized For Issuance For Services Rendered														82,893
Number Of Shares, Authorized For Issuance For Services Rendered																																																																																																													80,000					108,612
Shares Authorized For Issuance For Services Rendered, Value																																																																																																													24,000
Stock Issued During Period, Shares, Issued for Services		5,575,000																	2,512,500					765,713																																																																							1,333,333	525,000	3,000,000	2,107,000		140,000				3,881,978				1,000,000				1,059,394					4,379,122								2,225,750		662,027
Stock Issued During Period, Value, Issued for Services		1,115,000																	869,125																																																																												66,289	34,125	300,000	421,400		28,000								282,730				105,939					627,899	102,881							460,029
Proceeds From Stock Subscriptions											154,004
Common Stock, Shares Subscribed but Unissued											1,540,040
Legal Services Fee																			27,767
Stock Issued During Period Shares Issued For Services Satisfaction Of Liability																			1,000,000
Stock Issued During Period Values Issued For Services Satisfaction Of Liability																			841,358
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	21,757,578							21,757,578									21,757,578																																						8,279,028		21,757,578	18,802,820	5,000,000			1,000,000	1,000,000	500,000		500,000	1,000,000	1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross																																																									16,507,578	13,802,820		2,500,000	2,500,000																																										860,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date																																																																	29-Mar-13
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price																																																														$0.10	$0.15	$0.20		$0.20	$0.25	$0.30	$0.50
Number Of Warrants To Be Expired																																																									15,507,578													250,000	1,000,000	2,500,000	2,500,000
Share Price																																																						$0.50	$0.50														$0.26
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate																																																																					148.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate																																																																					0.27%
Share-Based Compensation Arrangement By Share-Based Payment Award, Option Value Price																																																																					$0.16
Share-Based Compensation Arrangement By Share-Based Payment Award, Option Value																																																																					$39,266
Share-Based Compensation Arrangement By Share-Based Payment Award, Option Aggregate Number																																																																					250,000
Debt Conversion, Converted Instrument, Shares Issued																																																																										10,097,331	2,135,000	7,498,099	575,000	3,344,721	50,000	50,000	50,000	200,000	125,000																																															4,131,328
Sale of Stock, Price Per Share			$0.20						$0.20														$0.80		$0.50
Adjustments To Additional Paid In Capital Share Purchased For Selling Of Warrants and Common Stock										2,279,028
Warrants Expire Date																																																							3-Jun-12
Extended Warrants Expire Date																																																							3-Jun-14
Warrants Expire Period																																																						2014-05

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	Jun. 30, 2013	Jun. 30, 2012
Net operating loss carryforward	$4,495,399	$3,610,256
Warrant issuances	171,374	171,374
Other	22,604	23,775
Valuation allowance	-4,689,377	-3,805,405
Deferred Tax Assets, Net	$0	$0

INCOME_TAXES_Details_1

INCOME TAXES (Details 1) (USD $)	12 Months Ended
INCOME TAXES (Details 1) (USD $)	Jun. 30, 2013	Jun. 30, 2012
Balance as of beginning of fiscal year	$164,869	$114,835
Increases related to prior year positions	0	50,034
Balance as of June 30,	$164,869	$164,869

INCOME_TAXES_Details_2

INCOME TAXES (Details 2)	12 Months Ended
INCOME TAXES (Details 2)	Jun. 30, 2013	Jun. 30, 2012
Tax on income before income tax	34.00%	34.00%
Effect of nontemporary differences	-0.66%	-1.04%
Effect of NOL true-up adjustment	-14.48%	0.00%
Change in valuation allowance	-18.86%	-32.96%
Effective Income Tax Rate, Continuing Operations	0.00%	0.00%

INCOME_TAXES_Details_Textual

INCOME TAXES (Details Textual) (USD $)	12 Months Ended
INCOME TAXES (Details Textual) (USD $)	Jun. 30, 2013
Operating Loss Carryforwards	$13,221,763
Operating Loss Carryforwards, Limitations on Use	available to offset future taxable income through 2032, which will begin to expire in 2022.

LITIGATION_Details_Textual

LITIGATION (Details Textual) (USD $)	12 Months Ended
In Billions, unless otherwise specified	Jun. 30, 2013
Litigation Settlement, Amount	$13.40